Charles River Laboratories | 资产

股票价格
189.21
每天变化
5.51 3.00%
每月一次
-12.71%
每年
15.52%
Q1 预测
183.40


金融业
股票价格
USD
资产
USD 7.51B
现金及等价物
USD 207.1M
销售成本
USD 693.46M
流动资产
USD 1.53B
流动负债
USD 1.12B
债务
USD 2.79B
EBIT
USD 133.8M
EBITDA
USD 282.89M
员工
18.6K
EPS每股收益
USD 2.43
股本和储备
USD 3.41B
销售毛利
USD 311.39M
债务利息支出
USD 25.4M
利息收入
USD 1.1
贷款资金
USD 2.19B
市值
USD 9.36B
净收入
USD 54.42M
营业费用
USD 3.41B
营业利润
USD 133.8M
普通股股本
USD 49.22M
PE价格收益
USD 42.72
税前利润
USD 170.03M
销售收入
USD 1B
销售和管理费用
USD 177.59M
股票
USD 302.55M
贸易债权人
USD 169.62M
应收帐款人
USD 1.48B


资产 更改 日
Agilent USD 12.73B 501M 2025-09
Align Technology USD 6.23B 141K 2025-12
Bio-Rad Laboratories USD 9.7B 517.7M 2025-09
Bruker USD 6.43B 95.1M 2025-09
Cardinal Health USD 58.08B 2.86B 2025-12
Charles River Laboratories USD 7.51B 46.73M 2025-09
Cigna USD 157.92B 6.27B 2025-09
CVS Health USD 255.33B 3.02B 2025-09
Danaher USD 83.46B 3.57B 2025-12
Dentsply International USD 5.65B 416M 2025-09
Elevance Health USD 121.49B 1.26B 2025-12
Galapagos EUR 3.51B 306.31M 2025-09
Hologic USD 9.18B 165.8M 2025-12
Humana USD 49.72B 638M 2025-09
Illumina USD 6.64B 467M 2025-12
Incyte USD 6.33B 509M 2025-09
IQVIA Holdings USD 29.94B 1.22B 2025-12
Laboratory Of America USD 18.26B 201.7M 2025-09
Lonza CHF 19.73B 1.85B 2024-12
McKesson USD 84.19B 30M 2025-12
Merck EUR 50.93B 3.58B 2025-09
Mettler Toledo International USD 3.71B 191.18M 2025-12
Novartis USD 107.29B 2.89B 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Quest Diagnostics USD 16.2B 228M 2025-09
Revvity USD 12.14B 223.84M 2025-09
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
United Therapeutics USD 7.35B 556.9M 2025-09
UnitedHealth USD 309.58B 5.69B 2025-12
Waters USD 4.86B 144.49M 2025-09
West Pharmaceutical Services USD 4.11B 153M 2025-09


Charles River Laboratories 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.